Design and synthesis of novel orexin 2 receptor agonists with a 1,3,5‑trioxazatriquinane skeleton
作者:Mao Amezawa、Naoshi Yamamoto、Yasuyuki Nagumo、Noriki Kutsumura、Yukiko Ishikawa、Masashi Yanagisawa、Hiroshi Nagase、Tsuyoshi Saitoh
DOI:10.1016/j.bmcl.2023.129151
日期:2023.2
asymmetric synthesis of a 1,3,5‑trioxazatriquinane skeleton using a Katsuki–Sharpless asymmetric epoxidation as the key reaction and obtained a set of the individual stereoisomers. After evaluating their activity, (+)-20d (EC50 = 3.87 μM for OX2R) and (+)-28d (EC50 = 1.62 μM for OX2R) were determined as eutomers for OX2R agonist activity. Our results provide a new class of skeleton consisting of an (R)-1,3
基于食欲素受体 (OXR) 与 TriMER 型 OXR 拮抗剂之间的对接模拟结果,设计合成了一系列具有氨基亚甲基侧链的多有效残基 1,3,5-三氧杂氮三喹烷 (TriMER) 衍生物。针对食欲素受体的体外筛选鉴定出六种具有顺式侧链构型的 TriMER 衍生物,其中20d和28d显示出对 OX 2的完全激动剂活性R 浓度为 10 µM。为了确定这些命中化合物的绝对立体化学,我们还使用 Katsuki–Sharpless 不对称环氧化作为关键反应进行了 1,3,5-三氧杂氮三喹烷骨架的首次不对称合成,并获得了一组单独的立体异构体。在评估它们的活性后,确定( + )- 20d( OX 2 R的 EC 50 = 3.87 μM )和 ( + )- 28d (OX 2 R 的EC 50 = 1.62 μM )作为 OX 2 R 激动剂活性的优异构体。我们的结果提供了一类新的骨架,由 ( R)-1